Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Infectious Diseases

• Publication date

  2018-06-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cid/ciy019PMID 29340592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis

  2017cited by this paper
• Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study

  2017cited by this paper
• Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis

  2016cited by this paper
• Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.

  2016cited by this paper
• Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis

  2015cited by this paper
• Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome.

  2015cited by this paper
• The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis

  2015cited by this paper
• The Wisconsin Hydrocephalus Survey: shunt-dependent hydrocephalus management style among members of the American Society of Pediatric Neurosurgeons

  2015cited by this paper
• Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.

  2014cited by this paper
• CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation

  2014cited by this paper
• The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

  2014cited by this paper
• Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.

  2014cited by this paper
• Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

  2014cited by this paper
• Treatment trials for post-Lyme disease symptoms revisited.

  2013cited by this paper
• Th1 and Th17 but no Th2-related cytokine spectrum in the cerebrospinal fluid of children with Borrelia-related facial nerve palsy

  2013cited by this paper
• Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

  2013cited by this paper
• Culture models to study leukocyte trafficking across the choroid plexus

  2013cited by this paper
• Interleukin-7: Fuel for the autoimmune attack.

  2013cited by this paper
• Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A.

  2013cited by this paper
• Diagnostic Value of Cytokines and Chemokines in Lyme Neuroborreliosis

  2013cited by this paper
• IL-7 in human health and disease.

  2012cited by this paper
• Cytokines of the γc family control CD4+ T cell differentiation and function

  2012cited by this paper
• Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study

  2011cited by this paper
• Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.

  2011cited by this paper
• CXCL13 chemokine in pediatric and adult neuroborreliosis

  2011cited by this paper
• Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid

  2011cited by this paper
• A prospective study on the role of CXCL13 in Lyme neuroborreliosis

  2011cited by this paper
• CXCL13 as a Cerebrospinal Fluid Marker for Neurosyphilis in HIV-Infected Patients With Syphilis

  2010cited by this paper
• Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

  2009cited by this paper
• The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis

  2009cited by this paper
• CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

  2009cited by this paper
• Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.

  2009cited by this paper
• Surveillance for Lyme disease--United States, 1992-2006.

  2008cited by this paper
• PRACTICE PARAMETER: TREATMENT OF NERVOUS SYSTEM LYME DISEASE (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY

  2008cited by this paper
• CSF B – lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008cited by this paper
• The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

  2006cited by this paper
• The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis

  2005cited by this paper
• Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

  2001cited by this paper
• Neuroactive kynurenines in Lyme borreliasis

  1992cited by this paper
• Central nervous system abnormalities in Lyme neuroborreliosis

  1991cited by this paper
• Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis

  1990cited by this paper
• Lyme neuroborreliosis

  1989cited by this paper

• Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies

  2024cites this paper
• Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis

  2024cites this paper
• Lyme Neuroborreliosis in the Context of Dementia Syndromes

  2024influential citation
• Environmental bacteria as triggers to brain disease: Possible mechanisms of toxicity and associated human risk.

  2022cites this paper
• Adverse Childhood Events, Post-Traumatic Stress Disorder, Infectious Encephalopathies and Immune-Mediated Disease

  2022cites this paper
• Diagnostic Testing for Lyme Disease.

  2022cites this paper
• Early Disseminated Lyme Disease: Cranial Neuropathy, Meningitis, and Polyradiculopathy.

  2022cites this paper
• Attenuation of relapsing fever neuroborreliosis in mice by IL-17A blockade

  2022cites this paper
• Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis

  2022cites this paper
• Stellenwert des CXCL-13 im Liquor als Frühmarker einer Neuroborreliose – Ein Fallbericht

  2022cites this paper
• Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis

  2022cites this paper
• Lyme neuroborreliosis: known knowns, known unknowns.

  2022cites this paper
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.

  2021cites this paper
• Spirochetal Infections of the Nervous System

  2021cites this paper
• A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system

  2021cites this paper
• Clinical mimics and diagnostic challenges in tick-borne borreliosis: a systematic review

  2021cites this paper
• Laboratory Diagnosis of Lyme Borreliosis

  2021cites this paper
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.

  2020cites this paper
• A Clinical Diagnostic System for Late-Stage Neuropsychiatric Lyme Borreliosis Based upon an Analysis of 100 Patients

  2020cites this paper
• Specificity and diagnostic utility of CSF CXCL13 in Lyme neuroborreliosis.

  2020cites this paper
• Diagnostic Utility of CXCL13 in Lyme Neuroborreliosis.

  2020cites this paper
• Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance

  2020influential citation
• Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes.

  2020cites this paper
• LYME DISEASE AND RELAPSING FEVER SPIROCHETES

  2020cites this paper
• Systemic immune responses in patients with early localized or early disseminated Borrelia afzelii lyme borreliosis

  2020cites this paper
• Studies on the pathogenesis and laboratory diagnosis of Lyme borreliosis

  2019cites this paper
• Neutrophil Extracellular Traps (NETs) in the Cerebrospinal Fluid Samples from Children and Adults with Central Nervous System Infections

  2019cites this paper
• A Neurologist's View of Lyme Disease and Other Tick-Borne Infections

  2019cites this paper
• Proposed Lyme Disease Guidelines and Psychiatric Illnesses

  2019cites this paper
• Lyme neuroborreliosis

  2019cites this paper
• Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections

  2018cites this paper
• Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET

  2018cites this paper
• Active neuroborreliosis or inflammation: are the diagnostic guidelines at stake?

  2018cites this paper
• Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States

  2018cites this paper